254 related articles for article (PubMed ID: 18596605)
1. Amyloid beta-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer's brain.
Aoki M; Volkmann I; Tjernberg LO; Winblad B; Bogdanovic N
Neuroreport; 2008 Jul; 19(11):1085-9. PubMed ID: 18596605
[TBL] [Abstract][Full Text] [Related]
2. Analysis of microdissected human neurons by a sensitive ELISA reveals a correlation between elevated intracellular concentrations of Abeta42 and Alzheimer's disease neuropathology.
Hashimoto M; Bogdanovic N; Volkmann I; Aoki M; Winblad B; Tjernberg LO
Acta Neuropathol; 2010 May; 119(5):543-54. PubMed ID: 20198479
[TBL] [Abstract][Full Text] [Related]
3. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
[TBL] [Abstract][Full Text] [Related]
4. Plasma antibodies to Abeta40 and Abeta42 in patients with Alzheimer's disease and normal controls.
Xu W; Kawarabayashi T; Matsubara E; Deguchi K; Murakami T; Harigaya Y; Ikeda M; Amari M; Kuwano R; Abe K; Shoji M
Brain Res; 2008 Jul; 1219():169-79. PubMed ID: 18534566
[TBL] [Abstract][Full Text] [Related]
5. Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons.
Clifford PM; Zarrabi S; Siu G; Kinsler KJ; Kosciuk MC; Venkataraman V; D'Andrea MR; Dinsmore S; Nagele RG
Brain Res; 2007 Apr; 1142():223-36. PubMed ID: 17306234
[TBL] [Abstract][Full Text] [Related]
6. Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer's disease.
El-Agnaf OM; Mahil DS; Patel BP; Austen BM
Biochem Biophys Res Commun; 2000 Jul; 273(3):1003-7. PubMed ID: 10891362
[TBL] [Abstract][Full Text] [Related]
7. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
Duyckaerts C; Perruchini C; Lebouvier T; Potier MC
Bull Acad Natl Med; 2008 Feb; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
[TBL] [Abstract][Full Text] [Related]
8. Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains.
Zhou XW; Li X; Bjorkdahl C; Sjogren MJ; Alafuzoff I; Soininen H; Grundke-Iqbal I; Iqbal K; Winblad B; Pei JJ
Neurobiol Dis; 2006 Jun; 22(3):657-68. PubMed ID: 16513361
[TBL] [Abstract][Full Text] [Related]
9. The turn formation at positions 22 and 23 in the 42-mer amyloid beta peptide: the emerging role in the pathogenesis of Alzheimer's disease.
Murakami K; Masuda Y; Shirasawa T; Shimizu T; Irie K
Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S169-79. PubMed ID: 20590832
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol depletion reduces aggregation of amyloid-beta peptide in hippocampal neurons.
Schneider A; Schulz-Schaeffer W; Hartmann T; Schulz JB; Simons M
Neurobiol Dis; 2006 Sep; 23(3):573-7. PubMed ID: 16777421
[TBL] [Abstract][Full Text] [Related]
11. Clearance of Alzheimer's Abeta peptide: the many roads to perdition.
Tanzi RE; Moir RD; Wagner SL
Neuron; 2004 Sep; 43(5):605-8. PubMed ID: 15339642
[TBL] [Abstract][Full Text] [Related]
12. Reduction of sortilin-1 in Alzheimer hippocampus and in cytokine-stressed human brain cells.
Zhao Y; Cui JG; Lukiw WJ
Neuroreport; 2007 Jul; 18(11):1187-91. PubMed ID: 17589324
[TBL] [Abstract][Full Text] [Related]
13. Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease.
Crowther DC; Kinghorn KJ; Miranda E; Page R; Curry JA; Duthie FA; Gubb DC; Lomas DA
Neuroscience; 2005; 132(1):123-35. PubMed ID: 15780472
[TBL] [Abstract][Full Text] [Related]
14. The role of amyloid beta peptide 42 in Alzheimer's disease.
Findeis MA
Pharmacol Ther; 2007 Nov; 116(2):266-86. PubMed ID: 17716740
[TBL] [Abstract][Full Text] [Related]
15. Intraneuronal Abeta42 accumulation in Down syndrome brain.
Mori C; Spooner ET; Wisniewsk KE; Wisniewski TM; Yamaguch H; Saido TC; Tolan DR; Selkoe DJ; Lemere CA
Amyloid; 2002 Jun; 9(2):88-102. PubMed ID: 12440481
[TBL] [Abstract][Full Text] [Related]
16. Plasma biomarkers of Alzheimer's disease.
Kawarabayashi T; Shoji M
Curr Opin Psychiatry; 2008 May; 21(3):260-7. PubMed ID: 18382225
[TBL] [Abstract][Full Text] [Related]
17. Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42: implications for the pathogenesis of Alzheimer's disease.
Hasegawa T; Ukai W; Jo DG; Xu X; Mattson MP; Nakagawa M; Araki W; Saito T; Yamada T
J Neurosci Res; 2005 Jun; 80(6):869-76. PubMed ID: 15898106
[TBL] [Abstract][Full Text] [Related]
18. Abeta43 is more frequent than Abeta40 in amyloid plaque cores from Alzheimer disease brains.
Welander H; Frånberg J; Graff C; Sundström E; Winblad B; Tjernberg LO
J Neurochem; 2009 Jul; 110(2):697-706. PubMed ID: 19457079
[TBL] [Abstract][Full Text] [Related]
19. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.
Cataldo AM; Petanceska S; Terio NB; Peterhoff CM; Durham R; Mercken M; Mehta PD; Buxbaum J; Haroutunian V; Nixon RA
Neurobiol Aging; 2004; 25(10):1263-72. PubMed ID: 15465622
[TBL] [Abstract][Full Text] [Related]
20. CD36 overexpression in human brain correlates with beta-amyloid deposition but not with Alzheimer's disease.
Ricciarelli R; D'Abramo C; Zingg JM; Giliberto L; Markesbery W; Azzi A; Marinari UM; Pronzato MA; Tabaton M
Free Radic Biol Med; 2004 Apr; 36(8):1018-24. PubMed ID: 15059642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
